Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ELN implementation challenges.

David J Drake1

  • 1AstraZeneca, 26F17/42 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. david.drake@astrazeneca.com

Drug Discovery Today
|August 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compound Passport Service: supporting corporate collection owners in open innovation.

Drug discovery today·2015
Same author

Case series of undetected intranasal impression material in patients with clefts.

The British journal of oral & maxillofacial surgery·2012
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Implementing Electronic Laboratory Notebooks (ELN) offers significant benefits to pharmaceutical companies. However, adoption presents challenges in managing scientific impact and technical integration, even with commercial solutions.

Area of Science:

  • Pharmaceutical industry
  • Laboratory informatics
  • Scientific data management

Background:

  • Electronic Laboratory Notebooks (ELN) are increasingly adopted in pharmaceutical settings.
  • ELNs offer benefits to both business operations and scientific personnel.
  • Their implementation is crucial for modernizing research and development.

Purpose of the Study:

  • To examine the challenges associated with implementing Electronic Laboratory Notebooks in established pharmaceutical organizations.
  • To analyze the impact of ELN implementation on scientists and technical aspects.
  • To understand the unique advantages and challenges of using third-party commercial ELN solutions.

Main Methods:

  • Qualitative analysis of implementation case studies.

Related Experiment Videos

  • Review of technical integration requirements for ELN systems.
  • Assessment of change management strategies for scientific staff.

    • Main Results:

    • ELN implementation necessitates careful management of scientific workflow disruptions.
    • Technical challenges include data integration, security, and system compatibility.
    • Commercial ELN adoption introduces supplier management as an additional layer of complexity.

    Conclusions:

    • Successful ELN implementation requires a holistic approach addressing both human and technical factors.
    • Pharmaceutical companies must proactively plan for change management and technical integration.
    • Strategic partnerships with third-party vendors can mitigate risks but require careful oversight.